This week I wanted to spotlight something Ive been hearing more and more about online and in practice, the unexpected impact GLP-1s can have on Aug 19, 2025 See all The GLP-1 Dietitian Hub Go to resource for health professionals working with GLP-1s
Specifically, the FDA has approved semaglutide for adults who are clinically obese (BMI of 30 or higher) or overweight (BMI of 27 or higher) when accompanied by at least one weight-related health condition, such as hypertension, hyperlipidemia, cardiovascular disease, prediabetes, or obstructive sleep apnea
however, the role of such cytokines in COVID-19 is unclear
This all feeds into a system that tells him how to improve those measurements
if the level of serum calcium exceeds 10.5mg/dl or urinary calcium in adults exceeds 4mg/kg day, stop dosing